Literature DB >> 15741607

Localization of the GLUT8 glucose transporter in murine kidney and regulation in vivo in nondiabetic and diabetic conditions.

Mario Schiffer1, Katalin Susztak, Mollie Ranalletta, Amanda C Raff, Erwin P Böttinger, Maureen J Charron.   

Abstract

Kidney disease is a major complication of diabetes, and poor glycemic control is associated with the development of diabetic nephropathy. The precise mechanisms that lead to diabetic kidney disease still remain largely unknown and are under current investigation. Because glucose transporters in the kidney play an important role in the local maintenance of intracellular glucose and plasma glucose homeostasis, the tissue distribution and regulation of glucose transporter GLUT8, a new member of the glucose transporter family with important functions in cellular survival, were examined. To understand the normal regulation of GLUT8 expression in response to metabolic signals, fasting and feeding conditions were studied. Additionally, GLUT8 expression was studied using two different models of insulin resistance, GLUT4-/- and db/db mice. GLUT8 was localized to glomerular podocytes and tubular epithelial cells in the distal portion of the nephron. Expression of GLUT8 in the kidney was influenced by plasma glucose levels in vivo. Podocytes in kidneys of diabetic db/db mice express higher levels of GLUT8 compared with nondiabetic db/m mice. Because podocytes play an important role in glomerulosclerosis development and high levels of glucose have been shown to induce apoptotic cell death in various kidney cells, these data may provide further insight into the pathogenesis of glomerulosclerosis and diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741607     DOI: 10.1152/ajprenal.00234.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

1.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Sweet debate: fructose versus glucose in diabetic kidney disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

3.  Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.

Authors:  Hongyu Zhang; MaryLee Schin; Jharna Saha; Kathleen Burke; Lawrence B Holzman; Wanda Filipiak; Thomas Saunders; Minghui Xiang; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

4.  Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1.

Authors:  R Lennon; G I Welsh; A Singh; S C Satchell; R J Coward; J M Tavaré; P W Mathieson; M A Saleem
Journal:  Diabetologia       Date:  2009-06-17       Impact factor: 10.122

Review 5.  Ion channels and transporters in diabetic kidney disease.

Authors:  Denisha Spires; Anna D Manis; Alexander Staruschenko
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

6.  Insulin signaling: implications for podocyte biology in diabetic kidney disease.

Authors:  Richard Coward; Alessia Fornoni
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

Review 7.  Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?

Authors:  Anita A Wasik; Sanna Lehtonen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-09       Impact factor: 5.555

8.  TrkC Is Essential for Nephron Function and Trans-Activates Igf1R Signaling.

Authors:  Carolin Lepa; Sascha Hoppe; Antje Stöber; Boris V Skryabin; Laura Katharina Sievers; Barbara Heitplatz; Giuliano Ciarimboli; Ute Neugebauer; Maja T Lindenmeyer; Clemens D Cohen; Hannes C A Drexler; Peter Boor; Thomas Weide; Hermann Pavenstädt; Britta George
Journal:  J Am Soc Nephrol       Date:  2020-12-30       Impact factor: 10.121

9.  Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.

Authors:  Johanna Guzman; Alexandra N Jauregui; Sandra Merscher-Gomez; Dony Maiguel; Cristina Muresan; Alla Mitrofanova; Ana Diez-Sampedro; Joel Szust; Tae-Hyun Yoo; Rodrigo Villarreal; Christopher Pedigo; R Damaris Molano; Kevin Johnson; Barbara Kahn; Bjoern Hartleben; Tobias B Huber; Jharna Saha; George W Burke; E Dale Abel; Frank C Brosius; Alessia Fornoni
Journal:  Diabetes       Date:  2013-10-07       Impact factor: 9.461

Review 10.  Lipid mediators of insulin signaling in diabetic kidney disease.

Authors:  Alla Mitrofanova; Marie Anne Sosa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.